Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829140 · ClinicalTrials.gov registry record · Phase 1
To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT00829140 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 56 participants.
The verdict
NCT00829140, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of lorcaserin on energy metabolism and food intake in obese and overweight patients.
Interventions
- DRUG Placebo
- DRUG Lorcaserin 10mg BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00829140
The ClinicalTrials.gov registry entry for NCT00829140 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00829140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00829140 about?
NCT00829140 is a clinical study titled "To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake". The purpose of this study is to evaluate the effect of lorcaserin on energy metabolism and food intake in obese and overweight patients.
What is the current status of trial NCT00829140?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2008-11. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00829140?
The interventions under investigation include: Placebo (DRUG), Lorcaserin 10mg BID (DRUG).
Who is sponsoring clinical trial NCT00829140?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.